1. Home
  2. BHVN vs PHI Comparison

BHVN vs PHI Comparison

Compare BHVN & PHI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BHVN
  • PHI
  • Stock Information
  • Founded
  • BHVN 2013
  • PHI 1928
  • Country
  • BHVN United States
  • PHI Philippines
  • Employees
  • BHVN N/A
  • PHI N/A
  • Industry
  • BHVN Biotechnology: Pharmaceutical Preparations
  • PHI Telecommunications Equipment
  • Sector
  • BHVN Health Care
  • PHI Telecommunications
  • Exchange
  • BHVN Nasdaq
  • PHI Nasdaq
  • Market Cap
  • BHVN 5.4B
  • PHI 5.3B
  • IPO Year
  • BHVN 2017
  • PHI 1953
  • Fundamental
  • Price
  • BHVN $45.17
  • PHI $22.64
  • Analyst Decision
  • BHVN Strong Buy
  • PHI
  • Analyst Count
  • BHVN 13
  • PHI 0
  • Target Price
  • BHVN $63.42
  • PHI N/A
  • AVG Volume (30 Days)
  • BHVN 729.5K
  • PHI 83.2K
  • Earning Date
  • BHVN 11-12-2024
  • PHI 11-12-2024
  • Dividend Yield
  • BHVN N/A
  • PHI 7.44%
  • EPS Growth
  • BHVN N/A
  • PHI 147.52
  • EPS
  • BHVN N/A
  • PHI 2.21
  • Revenue
  • BHVN N/A
  • PHI $3,846,163,485.00
  • Revenue This Year
  • BHVN N/A
  • PHI $4.57
  • Revenue Next Year
  • BHVN $179.00
  • PHI $4.14
  • P/E Ratio
  • BHVN N/A
  • PHI $10.36
  • Revenue Growth
  • BHVN N/A
  • PHI 3.33
  • 52 Week Low
  • BHVN $26.80
  • PHI $21.52
  • 52 Week High
  • BHVN $62.21
  • PHI $30.39
  • Technical
  • Relative Strength Index (RSI)
  • BHVN 38.20
  • PHI 35.83
  • Support Level
  • BHVN $43.18
  • PHI $22.03
  • Resistance Level
  • BHVN $54.53
  • PHI $22.57
  • Average True Range (ATR)
  • BHVN 2.57
  • PHI 0.49
  • MACD
  • BHVN -0.85
  • PHI 0.05
  • Stochastic Oscillator
  • BHVN 16.86
  • PHI 42.11

About BHVN Biohaven Ltd.

Biohaven Ltd is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology. Its product pipeline includes Glutamate, Myostatin, Ion channels, Inflammation & Immunology, and Oncology. Its products target diseases such as neuromuscular and metabolic diseases, antibody-drug conjugates for cancer, obsessive-compulsive disorder, and others.

About PHI PLDT Inc. Sponsored ADR

PLDT Inc is the telecommunications carrier in the Philippines. The company's business activities include three business units: Wireless, Fixed Line, and Others. The wireless segment consists of mobile telecommunications services provided by Smart and DMPI, and Fixed-line telecommunications services mainly provided by PLDT. It also provides fixed-line services through PLDT's subsidiaries.

Share on Social Networks: